Angle (AGL) RNS Announcements

Add to Alert list
Date Time Source Announcement
13 Dec 2024 08:43 AM
RNS
HER2 presentation at SABCS
15 Nov 2024 07:00 AM
RNS
Research on HER2 assay kit showcased at AACR
15 Nov 2024 07:00 AM
RNS
Parsortix based PD-L1 assay showcased at AACR
13 Nov 2024 07:00 AM
RNS
ANGLE presents two posters at EACR
11 Nov 2024 07:00 AM
RNS
Parsortix enriched CTC & ctDNA in NSCLC patients
17 Oct 2024 07:00 AM
RNS
Publication demonstrates CTC profiling potential
26 Sep 2024 07:01 AM
RNS
100th publication supporting Parsortix system use
26 Sep 2024 07:00 AM
RNS
Half-year Report
23 Sep 2024 07:00 AM
RNS
Exclusive agreement for DNA NGS panel
19 Sep 2024 07:00 AM
RNS
Agreement with Recursion Pharmaceuticals
17 Sep 2024 07:00 AM
RNS
Notice of Interim Results and Webcast
22 Aug 2024 07:00 AM
RNS
Data supporting FDA approval published in Journal
01 Aug 2024 07:00 AM
RNS
Independent Parsortix study
18 Jul 2024 10:08 AM
RNS
Standard form for notification of major holdings
12 Jul 2024 03:38 PM
RNS
Standard form for notification of major holdings
11 Jul 2024 03:07 PM
RNS
Result of 2024 Annual General Meeting
11 Jul 2024 03:07 PM
RNS
Result of 2024 Annual General Meeting
21 Jun 2024 07:00 AM
RNS
Result of open offer
18 Jun 2024 02:41 PM
RNS
Posting of 2023 Annual Report & Notice of the AGM
11 Jun 2024 07:00 AM
RNS
Parsortix and assays being showcased at EACR 2024
06 Jun 2024 04:37 PM
RNS
Publication of Circular
05 Jun 2024 04:04 PM
RNS
Results of placing and subscription
05 Jun 2024 07:00 AM
RNS
Proposed Placing, Subscription and Open Offer
05 Jun 2024 07:00 AM
RNS
Preliminary Results
16 May 2024 07:00 AM
RNS
Study of ovarian cancer CTCs using Parsortix
03 May 2024 07:00 AM
RNS
New commercial agreement with large pharma
24 Apr 2024 07:00 AM
RNS
New commercial agreement with AstraZeneca
22 Apr 2024 07:00 AM
RNS
US and EU patents for innovative CellKeep™ slide
08 Apr 2024 07:00 AM
RNS
Parsortix HER2 assay showcased at AACR 2024
22 Mar 2024 07:00 AM
RNS
Parsortix at European breast cancer conference
22 Jan 2024 07:00 AM
RNS
Potential utility in precision oncology
10 Jan 2024 12:57 PM
RNS
Standard form for notification of major holdings
04 Jan 2024 07:00 AM
RNS
Breakthrough clinical results
02 Jan 2024 07:00 AM
RNS
Contract announcement with Eisai Inc.
11 Dec 2023 07:00 AM
RNS
Broker Announcement
11 Dec 2023 07:00 AM
RNS
Parsortix unlocks opportunities for drug discovery
05 Dec 2023 07:00 AM
RNS
ANGLE launches Portrait+ CTC kit at SABCS
09 Nov 2023 07:00 AM
RNS
Launch of PD-L1 test to support cancer studies
09 Nov 2023 07:00 AM
RNS
Trading and business update
25 Oct 2023 07:00 AM
RNS
Supporting characterisation of CTCs in HNSCC
03 Oct 2023 07:00 AM
RNS
Parsortix outperforms standard for DTC harvest
29 Sep 2023 07:00 AM
RNS
Parsortix system showcased at ACTC conference
07 Sep 2023 07:00 AM
RNS
Interim Results for the period ended 30 June 2023
04 Sep 2023 07:00 AM
RNS
ANGLE launch of Portrait Flex assay
15 Aug 2023 07:00 AM
RNS
ANGLE notice of interim results
28 Jun 2023 04:54 PM
RNS
Result of 2023 Annual General Meeting
27 Jun 2023 12:24 PM
RNS
Standard form for notification of major holdings
05 Jun 2023 07:00 AM
RNS
ANGLE announces senior management appointments
25 May 2023 07:00 AM
RNS
Pharma services contract with Artios Pharma
22 May 2023 07:00 AM
RNS
Board change - appointment of new Chairman

ANGLE PLC is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company's product includes Parsortix cell separation system.

Founded in 1994, AGL share price listed on LSE in 2004 under the ticker AGL.

UK 100